US Stocks
/
RenovoRx, Inc. Share Price
RenovoRx, Inc. Share Price

RenovoRx, Inc. Share Price

NASDAQ: RNXT | Micro Cap
$1.70
-$0.02 (-1.45%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

RenovoRx, Inc. Stock Performance

Open
$1.70
Prev. Close
$1.72
Circuit Range
N/A
Day Range
$1.68 - $1.74
Year Range
$0.70 - $2.57
Volume
11,436
Average Traded
$1.71

RenovoRx, Inc. Share Price Today

As of 19 September 2026, RenovoRx, Inc.'s share price is $1.70. The stock opened at $1.70, compared to its previous close of $1.72. During today's trading session, RenovoRx, Inc.'s share price traded between $1.68 and $1.74, with an average price of $1.71. Over the past 52 weeks, the stock has recorded a high of $2.57 and a low of $0.70. In terms of performance, RenovoRx, Inc.'s share price has risen by 66.18% over the last six months and is up 33.99% on a year-on-year basis.

RenovoRx, Inc. Share Price Chart

$1.68$1.74
L
Show Current Price
H

RenovoRx, Inc. Stock Fundamentals & Key Indicators

Market Cap
$59.89M
PE Ratio (TTM)
-5.30
Dividend Yield
N/A
EPS (TTM)
$-0.32
Revenue (TTM)
$1.12M
Return On Equity (TTM)
-188.71%
Profit Margin
-911.13%
Debt to Equity
0.36
Quarterly Earnings Growth YoY
N/A

RenovoRx, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2025Jun 2025Sep 2025
Revenue$197000.00$422000.00$266000.00
Net Profit-$2.42M-$2.90M-$2.91M
Net Profit Margin-1228.43%-686.02%-1094.74%
Income ChangeN/A-19.63%-0.59%

RenovoRx, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$43000.00$1.12M
Net ProfitN/AN/A
Net Profit MarginN/AN/A
Income ChangeN/AN/A

About RenovoRx, Inc.

RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Mountain View, California.

RenovoRx, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$1.94
$1.69
+14.97%
Aug 2026
$0.96
$1.47
+53.13%
Jul 2026
$0.97
$0.96
-2.44%
Jun 2026
$0.92
$0.98
+8.01%
May 2026
$0.88
$0.91
+6.55%
Apr 2026
$1.02
$0.85
-16.18%
Mar 2026
$0.90
$1.02
+15.91%
Feb 2026
$1.03
$0.88
-15.38%
Jan 2026
$0.86
$1.04
+23.22%
Dec 2025
$0.89
$0.84
-6.22%
Nov 2025
$1.07
$0.90
-18.55%
Oct 2025
$1.31
$1.10
-12.65%

RNXT Share Price FAQs

What is RenovoRx, Inc. share price today?

chevron-up
RenovoRx, Inc. share price today is $1.70 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of RenovoRx, Inc. stock?

chevron-up
The 52 week high of RenovoRx, Inc. stock is $2.57, while the 52 week low is $0.70 as of 19 Sep '26.

What is RNXT's market capitalisation today?

chevron-up
RNXT market capitalisation is $59.89M as of September 19, 2026, at 1:46 am IST.

What is RNXT's net income for the last quarter?

chevron-up
RNXT's net income for the last quarter is -0.00B USD.

What is the 5 year returns of RNXT?

chevron-up
The 5 year returns of RNXT is -71.94% as on 19 Sep '26.

What is the high & low stock price of RNXT today?

chevron-up
RNXT stock price hit a high of $1.74 and low of $1.68 as of 19 Sep '26.

Can I buy RNXT shares in India?

chevron-up
Yes. You can buy RNXT in India by opening an international trading account.